OUR APPROACH
Target
Identify established, high-potential healthcare companies with a credible pathway to AI-native transformation and public-market transition.
Transform
Position companies for enterprise transformation through an AI-native operating model designed to support growth and efficiency.
Transition
Prepare companies for transition to global public markets with clear positioning, seasoned leadership, and strategic capital partners.
WHY ARX
Entrepreneurial Leadership
Experience across healthcare M&A, enterprise transformation through technology, and public-company leadership.
ARxi™
A developing transactional AI platform supporting target screening, diligence, transformation planning, and public-market readiness within a human-led, advisor-reviewed process.
Global Leadership Access
Access to a global network of CEOs and executive leaders across sectors, disciplines, and geographies.
Strategic Advisors
M&A and capital markets expertise, supported by healthcare, legal, accounting, and audit advisors across the transaction lifecycle.
ARxi is a developing and evolving platform. Its capabilities, workflows, integrations, and outputs are expected to advance over time and remain subject to human review, professional-advisor input, data availability, and applicable legal, regulatory, governance, and transaction requirements.
LEADERSHIP
Amro Albanna
Amro Albanna is a serial entrepreneur and public-company chief executive whose work spans three areas that rarely sit together: healthcare mergers and acquisitions, enterprise transformation through technology, and public capital markets execution.
Rowena Albanna
Rowena Albanna is a public-company operations executive with more than 25 years of leadership in technology and life sciences, building the operational infrastructure growth-stage companies need to scale and, more recently, leading the shift to AI-enabled operations.